top of page

The MRC is announcing a new ATMP related funding stream







Expression of interest: Prosperity partnerships: advanced therapies safety and toxicity


Opportunity status: Open

Funders: Medical Research Council (MRC)

Funding type: Grant

Total fund: £10,500,000

Award range: £2,000,000 - £4,000,000

Publication date: 30 August 2024

Opening date: 30 August 2024 9:00am UK time

Closing date: 6 November 2024 4:00pm UK time


Apply for funding to support emerging or established research partnerships between businesses and academic partners (lead must be UK-based).

Co-developed programmes should enhance knowledge of the safety and toxicity of advanced therapies, developing tools and resources to assess and mitigate safety risks. The research will integrate discovery and translational science, aiming to propel future advanced therapies into clinics.

Where justified, multiple partners can participate on either side of the partnership, with MRC funding academic costs of £2 million to £4 million FEC for up to five years. Equal contribution is expected by the business partner(s).


Timeline

30 August 2024 9:00am

Expression of interest opening date


10 October 2024

Webinar


6 November 2024 4:00pm

Expression of interest closing date


27 November 2024 9:00am

Full application opening date


12 February 2025 4:00pm

Full application closing date


March 2025

Shortlisting meeting


28 or 29 April 2025

Funding decision meeting (interviews)


To find out more

bottom of page